UAE Molecular Point of care Testing (Using NAAT) Market to 2032
Overview
The UAE Molecular Point of care Testing (Using NAAT) Market is expected to reach a 580.41 USD Million by 2032 and is projected to grow at a CAGR of 8.67% from 2025 to 2032.
Revenue, 2024 (USD Million)
345.34
Forecast, 2032 (USD Million)
580.41
CAGR, 2024 - 2032
8.67%
Report Coverage
UAE
UAE Molecular Point of care Testing (Using NAAT) Market 2018-2032 USD Million
UAE Molecular Point of care Testing (Using NAAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 345.34 USD Million
- Projected Market Size (2032): 580.41 USD Million
- CAGR (2025-2032): 8.67%
Key Findings of UAE Molecular Point of care Testing (Using NAAT) Market
- The UAE Molecular Point of care Testing (Using NAAT) Market was valued at 345.34 USD Million in 2024.
- The UAE Molecular Point of care Testing (Using NAAT) Market is likely to grow at a CAGR of 8.67% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Testing in Mode of Testing Segment accounted for the largest share of the market with a revenue of 325.95 USD Million
- The fastest growing segment Direct Sales in Distribution Channel Segment grew Fastest with a CAGR of 10.24% during the forecast period from 2024 to 2032.
UAE Molecular Point of care Testing (Using NAAT) Market Scope
UAE Molecular Point of care Testing (Using NAAT) Market Segmentation & Scope
Indication
- Others
- Gastrointestinal Tract Infections Testing
- Sexually Transmitted Infection (STI) Testing
- Respiratory Infections Testing
Product
- Instruments
- Consumables & Reagents
Distribution Channel
- Online Sales
- Third Party Distributor
- Direct Sales
Mode of Testing
- OTC Testing
- Prescription-Based Testing
End User
- Assisted Living Facilities
- Homecare
- Others
- Ambulatory Center
- Clinics
- Hospital
- Laboratories
UAE Molecular Point of care Testing (Using NAAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 345.34 USD Million |
| Market Value in 2032 | 580.41 USD Million |
| CAGR (2025-2032) | 8.67% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Indication, Product, Distribution Channel, Mode of Testing, End User |
Regional Insights:
-
Leading Market (2024-2032): UAE, leading in terms of revenue 345.34 USD Million in 2024
- Key Country: UAE, leading in terms of revenue with value of 345.34 USD Million in 2024.
Segments and Scope
-
UAE Molecular Point of care Testing (Using NAAT) Market to 2032, By Indication
- Respiratory Infections Testing is the largest segment in UAE Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 221.70 USD Million in the year 2024.
- Respiratory Infections Testing is the Fastest growing segment in UAE Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 9.95 % in forecast period 2025-2032.
-
UAE Molecular Point of care Testing (Using NAAT) Market to 2032, By Product
- Consumables & Reagents is the largest segment in UAE Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 269.01 USD Million in the year 2024.
- Consumables & Reagents is the Fastest growing segment in UAE Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 8.91 % in forecast period 2025-2032.
-
UAE Molecular Point of care Testing (Using NAAT) Market to 2032, By Distribution Channel
- Direct Sales is the largest segment in UAE Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 214.39 USD Million in the year 2024.
- Direct Sales is the Fastest growing segment in UAE Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 10.24 % in forecast period 2025-2032.
-
UAE Molecular Point of care Testing (Using NAAT) Market to 2032, By Mode of Testing
- Prescription-Based Testing is the largest segment in UAE Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 325.95 USD Million in the year 2024.
- Prescription-Based Testing is the Fastest growing segment in UAE Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 8.96 % in forecast period 2025-2032.
-
UAE Molecular Point of care Testing (Using NAAT) Market to 2032, By End User
- Laboratories is the largest segment in UAE Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 252.60 USD Million in the year 2024.
- Laboratories is the Fastest growing segment in UAE Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 9.45 % in forecast period 2025-2032.
UAE Molecular Point of care Testing (Using NAAT) Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Abbott | |||
| Hologic, Inc. | |||
| Danaher | |||
| F. Hoffmann-La Roche Ltd. | |||
UAE Molecular Point of care Testing (Using NAAT) Market Geographical Sales Distribution, 2018-2032 USD Million
UAE Molecular Point of care Testing (Using NAAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The UAE Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Indication, Product, Distribution Channel, Mode of Testing, End User.
UAE Molecular Point of care Testing (Using NAAT) Market was valued at USD 345.34(Revenue in USD Million) in 2022.
UAE Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 8.67% during the forecast period of 2024 to 2032.
The Prescription-Based Testing segment is expected to dominate the UAE Molecular Point of care Testing (Using NAAT) Market, holding a largest market share of 325.95 USD Million in 2024
Coming Soon....
UAE Molecular Point of care Testing (Using NAAT) Market Scope
UAE Molecular Point of care Testing (Using NAAT) Market Segmentation & Scope
Indication
- Others
- Gastrointestinal Tract Infections Testing
- Sexually Transmitted Infection (STI) Testing
- Respiratory Infections Testing
Product
- Instruments
- Consumables & Reagents
Distribution Channel
- Online Sales
- Third Party Distributor
- Direct Sales
Mode of Testing
- OTC Testing
- Prescription-Based Testing
End User
- Assisted Living Facilities
- Homecare
- Others
- Ambulatory Center
- Clinics
- Hospital
- Laboratories
Frequently Asked Questions
The UAE Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Indication, Product, Distribution Channel, Mode of Testing, End User.
UAE Molecular Point of care Testing (Using NAAT) Market was valued at USD 345.34(Revenue in USD Million) in 2022.
UAE Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 8.67% during the forecast period of 2024 to 2032.
The estimated market value of the UAE Molecular Point of care Testing (Using NAAT) Market for final year is USD 580.41 (USD Million).
UAE Molecular Point of care Testing (Using NAAT) Market Company Profiling
Frequently Asked Questions
The UAE Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Indication, Product, Distribution Channel, Mode of Testing, End User.
UAE Molecular Point of care Testing (Using NAAT) Market was valued at USD 345.34(Revenue in USD Million) in 2022.
UAE Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 8.67% during the forecast period of 2024 to 2032.
The estimated market value of the UAE Molecular Point of care Testing (Using NAAT) Market for final year is USD 580.41 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.